All three studies used 700 mg leronlimab. I don't know if we can extrapolate that dosage to any other condition. Was it the long COVID study in which the FDA wouldn't let Cytodyn use 700 mg? As long as it is as safe at 700 mg as it was at 350 mg, is there any reason that future trials cannot be conducted using 700 mg?